Impact of Residual Inducer on Titratable Expression Systems

PloS One
Taliman AfrozChase L Beisel

Abstract

Inducible expression systems are widely employed for the titratable control of gene expression, yet molecules inadvertently present in the growth medium or synthesized by the host cells can alter the response profile of some of these systems. Here, we explored the quantitative impact of these residual inducers on the apparent response properties of inducible systems. Using a simple mathematical model, we found that the presence of residual inducer shrinks the apparent dynamic range and causes the apparent Hill coefficient to converge to one. We also found that activating systems were more sensitive than repressing systems to the presence of residual inducer and the response parameters were most heavily dependent on the original Hill coefficient. Experimental interrogation of common titratable systems based on an L-arabinose inducible promoter or a thiamine pyrophosphate-repressing riboswitch in Escherichia coli confirmed the predicted trends. We finally found that residual inducer had a distinct effect on "all-or-none" systems, which exhibited increased sensitivity to the added inducer until becoming fully induced. Our findings indicate that residual inducer or repressor alters the quantitative response properties of titratable...Continue Reading

References

Oct 26, 1990·Science·R B Lobell, R F Schleif
Oct 1, 1993·Molecular Microbiology·M J Weickert, S Adhya
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·D A Siegele, J C Hu
Nov 14, 1997·Immunotechnology : an International Journal of Immunological Engineering·M A ClarkR L Ward
May 31, 2001·Microbiology and Molecular Biology Reviews : MMBR·I Chopra, M Roberts
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Rachael M Morgan-KissJohn E Cronan
Feb 11, 2004·The Journal of Biological Chemistry·Bernard LakayeLucien Bettendorff
Jul 15, 1957·Proceedings of the National Academy of Sciences of the United States of America·A Novick, M Weiner
Mar 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Thomas KuhlmanTerence Hwa
Aug 24, 2007·PLoS Biology·Erel LevineTerence Hwa
Nov 14, 2007·Genome Biology·Jeffrey E Barrick, Ronald R Breaker
Nov 16, 2007·Molecular Systems Biology·Robert Sidney CoxMichael B Elowitz
Oct 29, 2008·Molecular Systems Biology·Chase L BeiselChristina D Smolke
Nov 13, 2008·Journal of the American Chemical Society·Vandana SharmaYohei Yokobayashi
Jan 22, 2009·Angewandte Chemie·Markus WielandJörg S Hartig
May 21, 2009·Molecular Systems Biology·Nicolas E Buchler, Frederick R Cross
Oct 12, 2010·Applied and Environmental Microbiology·Shana ToppJustin P Gallivan
Nov 27, 2010·Science·Stephanie J CullerChristina D Smolke
Jan 1, 2009·Microbial Biotechnology·Trygve BrautasetSvein Valla
May 24, 2011·Methods in Enzymology·Daniel G Gibson
Jan 22, 2013·Cell·Alexander Serganov, Evgeny Nudler
Apr 17, 2014·ACS Synthetic Biology·Taliman AfrozChase L Beisel
Jul 1, 2014·Molecular Microbiology·Taliman AfrozChase L Beisel

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
flow cytometry

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.